 |
|
|
| |
Long-Term Persistence of HCV NS5A Variants After
Treatment With NS5A Inhibitor Ledipasvir
|
| |
| |
Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
David Wyles1, Alessandra Mangia2, Wendy Cheng3, Stephen Shafran4, Christian Schwabe5, Wen Ouyang6, Krishna Chodavarapu6,
John McNally6, Brian Doehle6 , Evguenia Svarovskaia6, Michael D. Miller6, Hongmei Mo6, Hadas Dvory-Sobol6
1University of California San Diego, California, USA; 2Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo, Italy; 3Royal Perth Hospital, Western Australia, Australia; 4University of Alberta, Edmonton, Canada; 5Auckland Clinical Studies Ltd, Auckland, New Zealand;
6Gilead Sciences, Inc., Foster City, California, USA
|
| |
|
|
|
|
|
